Neusoft Medical Launches New Products to Global Market at 2013 Spring CMEF
SHENYANG, China, April 23, 2013 /PRNewswire/ -- Neusoft Medical Systems Co., Ltd. ("Neusoft Medical"), a wholly owned subsidiary of Neusoft Corporation (SSE: 600718), today announced the launch of a variety of new products to the global market in the categories of CT, digital X-ray, diagnostic ultrasound system, and clinical examination equipment. These new products were exhibited at the Spring Edition of the 69th China International Medical Equipment Fair (CMEF) in Shenzhen. The Neusoft exhibit demonstrates the latest round of innovative solutions for the middle and high-end medical equipment market since its launch of China's first independently developed 64-slice CT Scanner last year. The new products demonstrate the Company's continuous investment in R&D as well as its commitment to bringing innovation to the international market.
The newly launched products include a dual-slice CT scanner (NeuViz Twin), digital mammography system (NeuCare Mammo DR), two models of diagnostic ultrasound systems (N700 and N900), and the fully automatic sample preprocessing system (MPAM), NeuCare Mammo DR, independently developed by Neusoft Medical, building on its R&D strength in developing digital X-ray equipment. An innovative design makes high-end digital mammography accessible to the general public. The fully automatic sample preprocessing system (MPAM) is the latest product developed by Neusoft A&T Diagnostics Co., Ltd., a subsidiary of Neusoft Medical. This product is equipped with a number of industry-leading technologies that can greatly improve work efficiency in laboratories, accuracy of test results, and safety of sample handling with reduced biological contamination.
Over the past 15 years, Neusoft Medical has also developed a wide range of advanced products with China's independent intellectual property rights, including magnetic resonance imaging, digital X-ray machine, diagnostic ultrasound system, laboratory automation, radiotherapy equipment, and nuclear medicine imaging equipment, enabling the offering of complete medical solutions covering the fields of diagnostic imaging and routine examination. Neusoft Medical was the first Chinese technology company to successfully develop and launch a CT scanner with independent intellectual property rights in 1998, making China one of the few countries in the world manufacturing CT scanners. Since then, Neusoft Medical has launched a PET scanner in 2009 and the NeuViz 64 multi-slice CT scanner in 2012. Both systems have been certified by FDA, CE, and SFDA.
Mr. Guo Yong, Vice President and Marketing Director of Neusoft Medical, states, "Neusoft Medical has always committed to the strategy of pursuing a sustainable, fast, and healthy growth. We will continue to increase investment in the R&D of new products, strengthen technological innovation and intellectual property rights management, improve core technical capabilities, and enhance the competitiveness of Neusoft Medical's products. In the future, Neusoft Medical will continue to create value for customers, partners, employees, and shareholders, and strive to become a world-leading medical equipment and service provider."
About Neusoft Medical
Neusoft Medical is based in Shenyang, China. As a wholly-owned subsidiary of Neusoft Corporation, Neusoft Medical has become the premier developer and manufacturer of advanced medical equipment in China. Combining strength in R&D, software development and system integration with collaboration with top medical institutes and academic institutions, Neusoft Medical has released more than 20 new products since its founding in 1998 and installed thousands of medical systems worldwide. To learn more, please visit: http://medical.neusoft.com/en/
For more information, please contact:
Terry Du
PR Manager
Neusoft Corporation
Phone: +86-24-8366-2306
Email: [email protected]
SOURCE Neusoft Corporation
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article